Parallel Advisors’s Kailera Therapeutics KLRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.3K Buy
+900
New +$15.2K ﹤0.01% 3032

Other funds holding KLRA

Parallel Advisors's KLRA Position: Q3 2026 in Review

Parallel Advisors opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 900 shares worth $10.3K. The stake represents ﹤0.01% of the portfolio and ranks #3032 among its holdings.

132 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.

  • Parallel Advisors held 900 shares of Kailera Therapeutics worth $10.3K as of Q3 2026.
  • Kailera Therapeutics was a new Parallel Advisors position in Q3 2026.
  • Kailera Therapeutics made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3032 holding.
  • 132 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.